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Introduction {#sec005}
============

The two most common upper digestive tract cancers worldwide, esophageal cancer and gastric cancer, are the sixth and third leading cause of cancer-related death, respectively \[[@pone.0173896.ref001]\]. Since the middle of the 20^th^ century, a steady decline in upper digestive tract cancer incidence has been observed in the majority of more developed countries in Northern America and Europe \[[@pone.0173896.ref002]--[@pone.0173896.ref004]\]. Similar decreasing trends have also been noted in areas with historically high rates, including Ukraine, Colombia, Ecuador, Japan, China and Korea, but the disease burden remains heavy in some developing countries \[[@pone.0173896.ref005], [@pone.0173896.ref006]\].

A long-term trend analysis from in China revealed that the all-cancer incidence rates were stable during 2000 through 2011 for males, whereas they increased significantly among females. In contrast, the mortality rates since 2006 have declined significantly for both males and females \[[@pone.0173896.ref005]\]. The four most common cancers diagnosed in China are lung, gastric, liver, and esophageal, accounting for 57% of all cancers diagnosed in China, compared with 18% in the United States \[[@pone.0173896.ref005], [@pone.0173896.ref007]\]. Gastric, esophageal, and liver cancers were identified as leading causes of cancer-related death \[[@pone.0173896.ref005]\]. Malignancies of both esophageal and gastric cancers have a particularly poor prognosis and lower survival rate as they typically cause no symptoms and thus are diagnosed with distant metastasis \[[@pone.0173896.ref008], [@pone.0173896.ref009]\].

Yangzhong is an island located in the middle of the Yangtze River, China. It consists of a group of small islands with a special geographical environment and life style \[[@pone.0173896.ref010]\]. Yangzhong has been reported as a high-risk area for both esophageal cancer and gastric cancer since the 1970s. In 1985, the Yangzhong Cancer Institute was established. In 1991, the Yangzhong Cancer Registry was developed \[[@pone.0173896.ref010]\]. Since 2004, massive screening and intervention programs for digestive tract caners have been implemented \[[@pone.0173896.ref011]\], but their effects on the morbidity and mortality of esophageal and gastric cancers have not been thoroughly investigated. Like other health indices, information on survival statistics is an important component in monitoring cancer control activities, which may suggest possible reasons for changes and provide targets for the improvement. Based on the local cancer registry database, we performed the current study to describe the long-term trends of the incidence, mortality and survival of upper digestive tract cancers in Yangzhong.

Methods {#sec006}
=======

Ethics statement {#sec007}
----------------

This project has been approved by the Institutional Review Board of Nanjing Medical University. Written informed consent was obtained from all participants.

Data source {#sec008}
-----------

Yangzhong is a county-level city in eastern China, with a population of 280,000 and an area of 327 km^2^ at the end of 2015. The Yangzhong Cancer Mortality Registry was established in 1985 and is organized and maintained by the Yangzhong Cancer Research Institute (affiliated with Yangzhong People's Hospital). In 1990, case reports of both cancer occurrence and death to the Yangzhong Cancer Registry became compulsory, and the registry has functioned well since 1991. The cancer registry covers the entire local population. Cancer cases are reported to the registry from multiple sources, including local hospitals, community health centers and village clinics. A standard notification card is used to report the information of cancer cases, including patient's demographic characteristics (name, date of birth, sex, address and occupation) and disease characteristics (type of cancer, cancer site, date of diagnosis, pathology, and treatment). Patients reported to Yangzhong Cancer Registry were followed to confirm their diagnosis and survival status. Both active case searching and passive case reporting methods were adopted. For passive follow-up, death information about patients with esophageal or gastric cancer was extracted from death certificates in the vital statistical section of Yangzhong Center for Disease Control and Prevention. Patients without death information were considered to be "alive" until the end time of our research. In addition, mortality data were matched with the cancer incidence database. Active follow-up was necessary in the absence of reliable health information. Home visits or postal/telephone enquiries were performed to confirm the essential information. We extracted data from 1991 to 2013 based on the registry database. All cancer cases identified as codes C15 (esophageal cancer) or C16 (gastric cancer) from the 10^th^ revision of the International Classification of Disease (ICD-10) were included in the analysis \[[@pone.0173896.ref012]\]. The information of death, living status or loss to follow-up were updated through December 31, 2015. Patients that were alive at the closing date, lost to follow-up or died by other causes were considered censored \[[@pone.0173896.ref013], [@pone.0173896.ref014]\].

Quality control {#sec009}
---------------

Data reported to the Cancer Registry were checked for eligibility and validity before being entered into the database. Quality was assessed based on the criteria of the International Agency for Research on Cancer/International Association of Cancer Registries (IARC/IACR). Additionally, data sorting, checking and evaluation were performed using relevant software, including Excel and IARC-crgTools \[[@pone.0173896.ref015], [@pone.0173896.ref016]\]. The proportion of morphological verification (MV %), percentage of cancer cases identified with death certification only (DCO %), mortality to incidence ratio (MI), percentage of uncertified cancer (UB %), and percentage of cancer with undefined or unknown primary site (secondary) (CPU %) were used to evaluate the completeness, validity and reliability of the data \[[@pone.0173896.ref017]\]. In the current study, the overall indicators of MV %, DCO %, and MI ratio were 71.23%, 2.98% and 0.65, respectively. The UB % and CPU % were less than 5% for both esophageal and gastric cancers.

Statistical analyses {#sec010}
--------------------

The annual age-standardized rate and age-specific rate were calculated from 1991 through 2013. The age-adjusted rates represent a weighted average of the age-specific rates in which the weights are the proportions of persons in the corresponding age group of the standard population. This method reduced the potential confounding effect caused by age. We calculated the world age-standardized rate according to Segi's world standard population \[[@pone.0173896.ref018]\]. Cancer trends were calculated using the Joinpoint Regression Program and were reported using the annual percentage change (APC). Joinpoint Regression Program 4.3.1.0 was downloaded from the website of the National Cancer Institute (NCI, MD, USA). The Kaplan-Meier estimator was used to plot the survival curves. The 3-year cancer-specific survival rates (proportion of patients alive at the specified time) were calculated. Survival analysis between groups was performed using the log-rank test \[[@pone.0173896.ref019]\]. All statistical analyses were performed using SPSS 18.0 or STATA 10.0 software.

Results {#sec011}
=======

Esophageal cancer {#sec012}
-----------------

From 1991 to 2013, 6493 esophageal cancer cases were identified in Yangzhong County. Among them, 3446 (53.1%) were men and 3047 (46.9%) were women. The crude incidence rate of esophageal cancer was relatively stable during the study period, but the age-standardized incidence significantly decreased from 107.06 per 100,000 person-years (male: 118.05 per 100,000 person-years; female: 97.42 per 100,000 person-years) in 1991 to 37.04 per 100,000 person-years (male: 46.43 per 100,000 person-years; female: 27.26 per 100,000 person-years) in 2013, with an APC of -2.5% (95% CI: -3.4%, -1.5%) for males (P \<0.01) and -4.9% (95% CI: -5.8%, -3.9%) for females (P \<0.01) (Tables [1](#pone.0173896.t001){ref-type="table"} and [2](#pone.0173896.t002){ref-type="table"}; [Fig 1A](#pone.0173896.g001){ref-type="fig"}). The age-specific rates were relatively low in populations younger than 40 years and increased with age, reaching the peak at 75 years of age ([Fig 2A](#pone.0173896.g002){ref-type="fig"}). The age-specific rate was higher in males than in females for each age group.

![Age-adjusted incidence rates of esophageal and gastric cancers in Yangzhong.\
A: esophageal cancer; B: gastric cancer.](pone.0173896.g001){#pone.0173896.g001}

![Age-specific incidence rates of esophageal and gastric cancer in Yangzhong.\
A: esophageal cancer; B: gastric cancer.](pone.0173896.g002){#pone.0173896.g002}
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###### Incidence rate of esophageal and gastric cancer in Yangzhong, 1991--2013.

![](pone.0173896.t001){#pone.0173896.t001g}

  Cancers             Year   Male     Female   Total                                                 
  ------------------- ------ -------- -------- -------- -------- -------- -------- -------- -------- --------
  Esophageal cancer   1991   159      117.60   118.05   150      108.15   97.42    309      112.82   107.06
  1992                131    96.96    92.13    173      124.91   110.54   304      111.11   101.28   
  1993                145    107.40   99.28    122      88.21    74.06    267      97.69    85.75    
  1994                137    101.55   88.36    152      110.06   89.14    289      105.86   89.03    
  1995                125    92.72    79.61    151      109.49   84.92    276      101.20   82.51    
  1996                147    109.12   89.86    158      114.73   85.04    305      111.96   87.97    
  1997                149    110.68   87.04    117      85.08    64.09    266      97.75    74.91    
  1998                132    98.12    75.22    157      114.33   83.09    289      106.31   79.81    
  1999                157    116.79   86.92    162      118.14   81.97    319      117.48   84.46    
  2000                159    118.35   85.66    142      103.66   71.80    301      110.94   78.54    
  2001                155    115.43   82.08    162      118.39   77.34    317      116.93   80.39    
  2002                154    114.81   78.20    129      94.48    57.98    283      104.56   67.88    
  2003                163    121.52   84.74    138      101.07   63.74    301      111.21   74.37    
  2004                164    122.10   82.55    140      102.48   64.99    304      112.21   74.19    
  2005                182    135.31   90.37    132      96.56    58.07    314      115.78   74.17    
  2006                184    136.28   86.55    138      100.08   59.13    322      117.99   73.13    
  2007                146    107.85   64.99    120      86.64    51.69    266      97.13    58.07    
  2008                86     63.35    38.96    76       54.69    28.59    162      58.97    33.86    
  2009                156    113.31   69.03    111      78.42    45.84    267      95.63    57.22    
  2010                160    115.32   64.40    106      74.21    39.7     266      94.47    51.79    
  2011                154    111.50   62.30    104      73.08    36.14    258      92.01    49.00    
  2012                174    126.17   66.02    118      82.55    38.03    292      103.97   51.44    
  2013                127    91.92    46.43    89       62.05    27.26    216      76.71    37.04    
  Gastric cancer      1991   300      221.90   225.39   171      123.29   113.34   471      171.97   165.11
  1992                258    190.97   183.73   165      119.13   103.24   423      154.61   141.72   
  1993                235    174.07   161.61   157      113.52   91.72    392      143.43   125.9    
  1994                247    183.09   162.87   163      118.03   93.97    410      150.18   126.86   
  1995                264    195.83   170.26   140      101.52   76.94    404      148.14   121.69   
  1996                242    179.64   150.44   150      108.92   82.11    392      143.89   115.37   
  1997                222    164.92   131.57   138      100.35   76.47    360      132.29   102.85   
  1998                225    167.27   133.51   143      104.14   75.62    368      135.38   103.29   
  1999                209    155.48   118.93   140      102.10   69.36    349      128.53   93.54    
  2000                242    180.13   133.52   143      104.40   70.6     385      141.90   100.12   
  2001                251    186.93   134.88   136      99.40    64.57    387      142.75   98.19    
  2002                248    184.90   126.2    170      124.51   77.59    418      154.44   101      
  2003                252    187.88   128.35   136      99.61    65.71    388      143.35   96.05    
  2004                228    169.76   118.35   112      81.99    52.75    340      125.50   84.99    
  2005                260    193.31   128.28   129      94.37    60.01    389      143.44   92.87    
  2006                265    196.27   123.33   133      96.46    58.45    398      145.84   90.27    
  2007                228    168.43   102.39   153      110.48   62.31    381      139.12   81.98    
  2008                114    83.99    49.59    71       51.09    30.12    185      67.35    39.26    
  2009                237    172.15   107.25   137      96.79    52.78    374      133.95   79.16    
  2010                250    180.19   104.21   84       58.81    30.22    334      118.62   66.32    
  2011                236    170.88   94.3     120      84.33    42.22    356      126.96   67.86    
  2012                240    174.04   92.64    93       65.06    33.24    333      118.57   62.26    
  2013                206    149.10   76.51    94       65.54    32.43    300      106.54   53.46    

Abbreviations: N, number of cases; CR, crude rate; ASR, age-standardized rate.

10.1371/journal.pone.0173896.t002

###### Joinpoint analysis of esophageal and gastric cancers in Yangzhong, 1991--2013.

![](pone.0173896.t002){#pone.0173896.t002g}

  Cancers             Gender               Incidence          Mortality                                                                
  ------------------- -------------------- ------------------ ------------------ ------------ ------------------- -------------------- -----
  Esophageal cancer   Total                1991--2013         -3.5(-4.3, -2.7)   \<0.01       1991--1993          47.5(-14.4, 154.1)   0.1
  1993--2004          -2.9(-5.8, 0.5)      0.1                                                                                         
  2004--2010          -17.7(-26.2, -8.3)   \<0.01                                                                                      
  2010--2013          16.8(-11.4, 53.9)    0.2                                                                                         
  Male                1991--2013           -2.5(-3.4, -1.5)   \<0.01             1991--1993   41.9(-23, 161.5)    0.2                  
  1993--2004          -2.3(-5.6, 1.1)      0.2                                                                                         
  2004--2010          -15(-24.2, -4.7)     \<0.01                                                                                      
  2010--2013          15.3(-13.6, 53.8)    0.3                                                                                         
  Female              1991--2013           -4.9(-5.8, -3.9)   \<0.01             1991--2000   1.5(-4.8, 8.1)      0.6                  
  2000--2013          -11.9(-15.5, -8.1)   \<0.01                                                                                      
  Gastric cancer      Total                1991--2013         -4.0(-4.8, -3.2)   \<0.01       1991--2001          1.1(-2.8, 5.2)       0.6
  2001--2011          -13.8(-18.3, -8.9)   \<0.01                                                                                      
  2011--2013          34.4(-26.6, 146.1)   0.3                                                                                         
  Male                1991--2013           -3.6(-4.5, -2.7)   \<0.01             1991--1993   38.5(-7.9, 108.3)   0.1                  
  1993--2002          -1.9(-4.9, 1.2)      0.2                                                                                         
  2002--2011          -13.5(-16.9, -10)    \<0.01                                                                                      
  2011--2013          40(-1.1, 98.2)       0.1                                                                                         
  Female              1991--2013           -4.8(-5.7, -3.9)   \<0.01             1991--1999   2.4(-4.9, 10.2)     0.5                  
  1999--2013          -11(-14.3, -7.6)     \<0.01                                                                                      

Abbreviations: APC, annual percentage change; CI, confidence interval.

The age-standardized mortality rate for esophageal cancer increased from 1991 (25.15 per 100,000 person-years) to 1993 (62.94 per 100,000 person-years), remained stable from 1994 (56.38 per 100,000 person-years) to 2003 (50.78 per 100,000 person-years) and then decreased from 2004 (45.32 per 100,000 person-years) to 2011 (13.98 per 100,000 person-years), with a significant APC of -17.7% (95% CI: -26.2%, -8.3%; P \<0.01) (Tables [2](#pone.0173896.t002){ref-type="table"} & [3](#pone.0173896.t003){ref-type="table"}; [Fig 3A](#pone.0173896.g003){ref-type="fig"}).

![Age-adjusted mortality rates of esophageal and gastric cancers in Yangzhong.\
A: esophageal cancer; B: gastric cancer.](pone.0173896.g003){#pone.0173896.g003}
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###### Mortality rate of esophageal and gastric cancers in Yangzhong, 1991--2013.

![](pone.0173896.t003){#pone.0173896.t003g}

  Cancers             Year   Male     Female   Total                                             
  ------------------- ------ -------- -------- ------- ------- ------- ------- -------- -------- -------
  Esophageal cancer   1991   43       31.81    33.96   30      21.63   19.17   73       26.65    25.15
  1992                63     46.63    44.91    92      66.43   57.73   155     56.65    51.9     
  1993                104    77.04    71.36    93      67.24   55.6    197     72.08    62.94    
  1994                87     64.49    56.91    96      69.51   56.22   183     67.03    56.38    
  1995                103    76.41    65.87    118     85.56   66.03   221     81.04    66.05    
  1996                103    76.46    62.57    106     76.97   57.35   209     76.72    60.82    
  1997                91     67.60    53.56    90      65.45   45.02   181     66.51    49.41    
  1998                104    77.31    60.39    87      63.36   46.14   191     70.26    52.89    
  1999                125    92.99    69.45    123     89.70   61.13   248     91.33    65.85    
  2000                92     68.48    50.72    120     87.61   58.14   212     78.14    54.11    
  2001                102    75.96    54.24    96      70.16   45.53   198     73.04    50.39    
  2002                103    76.79    52.36    91      66.65   39.56   194     71.68    46.23    
  2003                101    75.30    52.56    108     79.10   48.37   209     77.22    50.78    
  2004                100    74.45    50.53    88      64.42   39.46   188     69.39    45.32    
  2005                107    79.55    52.45    76      55.60   34.73   183     67.48    43.58    
  2006                62     45.92    28.32    53      38.44   21.61   115     42.14    25.17    
  2007                62     45.80    27.52    48      34.66   18.18   110     40.17    22.86    
  2008                61     44.94    27.93    47      33.82   17.77   108     39.32    22.46    
  2009                55     39.95    23.77    40      28.26   14.88   95      34.02    19.3     
  2010                52     37.48    21.07    30      21.00   10.33   82      29.12    15.68    
  2011                47     34.03    17.67    32      22.49   10.6    79      28.17    13.98    
  2012                82     59.46    31.76    49      34.28   15.69   131     46.65    23.5     
  2013                73     52.84    26.65    55      38.35   16.02   128     45.46    21.57    
  Gastric cancer      1991   63       46.60    49.33   43      31.00   28.11   106      171.97   37.09
  1992                134    99.19    96.83    109     78.70   66.07   243     154.61   81.59    
  1993                158    117.04   108.79   83      60.01   47.97   241     143.43   77.06    
  1994                165    122.31   111.66   101     73.13   56.24   266     150.18   92.25    
  1995                183    135.75   117.45   133     96.44   74.05   316     148.14   94.02    
  1996                154    114.32   97.58    96      69.71   52.06   250     143.89   73.73    
  1997                170    126.29   102.1    94      68.36   49.47   264     132.29   75.50    
  1998                157    116.71   90.69    119     86.66   63.35   276     135.38   76.10    
  1999                187    139.12   108.96   120     87.51   59.56   307     128.53   82.75    
  2000                188    139.94   104.66   108     78.85   51.44   296     141.90   77.75    
  2001                188    140.01   100.29   97      70.89   46.42   285     142.75   71.85    
  2002                170    126.74   88.17    101     73.98   46.25   271     154.44   66.43    
  2003                177    131.96   91.41    88      64.45   42.97   265     143.35   66.36    
  2004                131    97.54    67.82    79      57.83   37.68   210     125.50   51.81    
  2005                141    104.83   69.13    97      70.96   43.72   238     143.44   56.28    
  2006                88     65.18    40.87    42      30.46   18.77   130     145.84   28.87    
  2007                111    82.00    50.96    52      37.55   20.64   163     139.12   35.58    
  2008                91     67.04    38.79    45      32.38   18.2    136     67.35    27.88    
  2009                68     49.39    30.78    36      25.43   12.5    104     133.95   21.24    
  2010                74     53.34    31.04    40      28.00   14.84   114     118.62   22.48    
  2011                60     43.44    24.34    34      23.89   10.59   94      126.96   17.37    
  2012                112    81.22    42.67    39      27.28   13.96   151     118.57   27.70    
  2013                127    91.92    47.34    56      39.04   18.56   183     106.54   32.11    

Abbreviations: N, number of cases; CR, crude rate; ASR, age-standardized rate.

Gastric cancer {#sec013}
--------------

From 1991 through 2013, 8537 patients were diagnosed with gastric cancer, of which 5459 (63.9%) were men and 3078 (36.1%) were women. The crude incidence rate of gastric cancer declined throughout the study period, and the age-standardized incidence rate declined significantly from 165.11 per 100,000 person-years (male: 225.39 per 100,000 person-years; female: 113.34 per 100,000 person-years) in 1991 to 53.46 per 100,000 person-years (male: 76.51 per 100,000 person-years; female: 32.43 per 100,000 person-years) in 2013. The APC was -3.6% (95% CI: -4.5%, -2.7%) for males (P \<0.01) and -4.8% (95% CI: -5.7%, -3.9%) for females (P \<0.01), according to the age-standardized incidence rate (Tables [1](#pone.0173896.t001){ref-type="table"} and [2](#pone.0173896.t002){ref-type="table"}; [Fig 1B](#pone.0173896.g001){ref-type="fig"}). The age-specific rates were relatively low in populations younger than 45 years and then increased significantly with age, reaching the peak at 70 years ([Fig 2B](#pone.0173896.g002){ref-type="fig"}). Similar to esophageal cancer, the age-specific rate was higher in males than in females in each age group.

The age-standardized mortality rate for gastric cancer fluctuated during 1992 (81.59 per 100,000 person-years) and 2001 (71.85 per 100,000 person-years), and then decreased significantly from 2002 (66.43 per 100,000 person-years) to 2011 (17.37 per 100,000 person-years), with an APC of -13.5% (95% CI: -16.9%, -10.0%; P \<0.01) (Tables [2](#pone.0173896.t002){ref-type="table"} and [3](#pone.0173896.t003){ref-type="table"}; [Fig 3B](#pone.0173896.g003){ref-type="fig"}).

Survival analysis {#sec014}
-----------------

All cancer patients were followed for survival status and cause of death. Through December 31, 2015, 3940 (60.7%) of the 6493 esophageal cancer patients and 5228 (61.2%) of 8537 gastric cancer patients died of cancer-related causes. The median survival time was 2.99 years for patients with esophageal cancer and 2.92 years for patients with gastric cancer. The 3-year survival rate for esophageal cancer increased from 25.89% (95% CI: 21.15%, 30.87%) in 1991 to 60.88% (95% CI: 55.02%, 66.21%) in 2012 (P for trend \<0.001). The 3-year survival rate for gastric cancer increased from 27.81% (95% CI: 23.84%, 31.91%) in 1991 to 62.13% (95% CI: 56.69%, 67.10%) in 2012 (P for trend \<0.001) ([Fig 4](#pone.0173896.g004){ref-type="fig"}).

![Three-year survival rates of esophageal and gastric cancers in Yangzhong.](pone.0173896.g004){#pone.0173896.g004}

As a massive endoscopic screening program was initiated in 2004 in Yangzhong, we compared the survival rates of two time periods (1991--2003 and 2004--2012). As shown in [Fig 5](#pone.0173896.g005){ref-type="fig"}, a significantly positive prognosis was observed among patients diagnosed after 2004 (Log-rank test: P \<0.001).

![Survival curves of upper digestive tract cancer before and after 2004.](pone.0173896.g005){#pone.0173896.g005}

Discussion {#sec015}
==========

Esophageal cancer and gastric cancer are two common cancers in China. Despite the declining trends of them worldwide \[[@pone.0173896.ref005]\], the absolute number of cases in China is enormous, partly due to the population size and age \[[@pone.0173896.ref020], [@pone.0173896.ref021]\]. In this longitudinal study, we observed declining trends in the incidence and mortality rates of both esophageal and gastric cancers. Survival analyses showed that the survival probability of patients with esophageal and gastric cancer in Yangzhong has significantly improved during the most recent decades.

The incidence and mortality rates of upper digestive tract cancers were not entirely consistent in different areas. Esophageal cancer is a relatively rare form of cancer but some countries like China, Iran, India, and Japan have a higher incidence than others \[[@pone.0173896.ref022]\]. There is considerable variation in the incidence of gastric cancer among different geographic regions in the world, with nearly two-thirds occurring in developing countries \[[@pone.0173896.ref022]\]. In Asia, the highest incidence of gastric cancer has been reported from some eastern countries such as China, Korea and Japan and the low incidence rates are found in south Asia \[[@pone.0173896.ref005], [@pone.0173896.ref022]\]. Even in China, there is a considerable variation in the incidence of both esophageal cancer and gastric cancer. For example, the estimated new cases of esophageal cancer was 364,100 in rural areas which was significantly higher than that in urban areas (113,800) \[[@pone.0173896.ref005]\]. Possible reasons for the variation in incidence and mortality include racial differences, environment, diet, cooking habits, behaviors, effectiveness of prevention, early detection and management of cancer cases in different areas \[[@pone.0173896.ref001], [@pone.0173896.ref021], [@pone.0173896.ref023]--[@pone.0173896.ref026]\]. The incidence rate in the study area increased sharply among people aged more than 40 years and reached to a peak during the age group of 70--75 years. This suggests that we can select residents aged 40--69 years as candidates for cancer screening.

Previous studies in Yangzhong have revealed that hot-temperature food items, pork braised in brown sauce, old stocked rice intake, pickled vegetables, and drinking river water increase the risk of esophageal cancer or gastric cancer \[[@pone.0173896.ref025], [@pone.0173896.ref027]\]. In recent decades, Yangzhong has undergone rapid economic growth. Living conditions and standards have significantly improved. Everyone has access to safe tap water. The dietary pattern has undergone great changes, and the nutritional status of the local population has also improved. These factors may contribute to the decrease in incidence of upper digestive tract cancers. But the rapid growth of the population, aging, increased tobacco smoking, and H. pylori infection may also contribute to the burden of gastrointestinal cancer \[[@pone.0173896.ref021], [@pone.0173896.ref028]\].

The good to excellent prognosis of patients with upper digestive tract cancers in the United States is mainly due to early detection and early treatment \[[@pone.0173896.ref028], [@pone.0173896.ref029]\]. Although prevention efforts are critical to reduce the long-term burden of cancer, the effects of intervention may not be seen immediately \[[@pone.0173896.ref005]\]. Therefore, facilitating the early diagnosis of cancer and improving access to and availability of optimal treatments may have the greatest potential to have a significant impact on the existing burden of cancer in China \[[@pone.0173896.ref030]\]. Many studies have shown that endoscopic screening is effective for the early detection of upper digestive tract cancers, thus reducing incidence and fatality \[[@pone.0173896.ref031]\]. In 2004, an early detection and treatment program was initiated in China \[[@pone.0173896.ref032]\]. As a pilot site, Yangzhong was selected to implement a population-based endoscopic screening program for early detection and treatment of esophageal and gastric cancer. One of our previous studies revealed a significant positive effect on the survival of patients diagnosed through massive endoscopic screening \[[@pone.0173896.ref011]\]. In this study, by comparing the age of diagnosis before and after 2004, we found a mean age shift from 65.09 years to 62.11 years (P \<0.001), which may be partially attributed to the screening program. However, caution is required in interpreting the long-term survival rate in [Fig 5](#pone.0173896.g005){ref-type="fig"}, as the follow-up time in this study was not longer enough to allow a precise estimation of survival beyond five-years.

The present study has several limitations. First, we lack necessary information to analyze the variation in subtypes of esophageal and gastric cancers. Due to the retrospective nature of this study, we failed to obtain all the necessary variables to control the bias in estimating the survival rate. Second, we need to be cautious in interpreting the results regarding trends of cancer occurrence and in linking the longitudinal trends to the implementation of the screening program. Variation in exposure to environmental risk factors or changes in lifestyle across this period may also play an important role. Third, the intention of screening is to diagnose a disease earlier than it would be without screening. However, the leading time bias may contribute to the increase in survival percentage after 2004. This is an important factor when evaluating the effectiveness of the endoscopic screening program. Fourth, The possible \"period effects\", which would have been associated with the improved completeness of the registries over time or the introduction of new diagnostic tools in recent years, could not be ruled out. However, such period effects might have contributed to artificially increased trends rather than decreasing trends as observed in this study.

Conclusion {#sec016}
==========

The age-standardized incidence rates of both esophageal and gastric cancer continuously decreased from 1991 through 2013, whereas the mortality rate remained stable before 2004 and significantly declined following the massive endoscopic screening program initiated in 2004. The survival probability of patients with esophageal and gastric cancer has improved in recent decades. Information from this study provides a better understanding of survival differences that are influenced by changing prevention and treatment strategies.
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